Thu, September 5, 2024
Wed, September 4, 2024
Tue, September 3, 2024

Mason Carrico Reiterated (TXG) at Buy and Held Target at $30 on, Sep 4th, 2024


//stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-30-on-sep-4th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Mason Carrico of Stephens & Co., Reiterated "10x Genomics, Inc." (TXG) at Buy and Held Target at $30 on, Sep 4th, 2024.

Mason has made no other calls on TXG in the last 4 months.



There are 13 other peers that have a rating on TXG. Out of the 13 peers that are also analyzing TXG, 6 agree with Mason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Dan Leonard of "UBS" Maintained at Hold with Decreased Target to $25 on, Tuesday, August 13th, 2024
  • Rachel Vatnsdal of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $20 on, Thursday, July 18th, 2024
  • Derik De Bruin of "B of A Securities" Maintained at Hold with Decreased Target to $25 on, Thursday, July 18th, 2024
  • Justin Bowers of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $25 on, Wednesday, July 10th, 2024
  • Doug Schenkel of "Wolfe Research" Downgraded from Buy to Hold on, Thursday, June 27th, 2024
  • Subbu Nambi of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, June 26th, 2024


These are the ratings of the 7 analyists that currently disagree with Mason


  • Mike Kratky of "Leerink Partners" Initiated at Buy and Held Target at $35 on, Tuesday, September 3rd, 2024
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $46 on, Tuesday, August 13th, 2024
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $32 on, Tuesday, July 23rd, 2024
  • Tycho Peterson of "Jefferies" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, July 22nd, 2024
  • Daniel Arias of "Stifel" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, July 16th, 2024
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $16 on, Tuesday, July 9th, 2024
  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $24 on, Friday, June 28th, 2024

Publication Contributing Sources